Acerus Announces Resignation of Norma Beauchamp As Director

TORONTO--(BUSINESS WIRE)-- Acerus Pharmaceuticals Corporation (TSX:ASP, OTCQB: ASPCF) (“Acerus” or the “Company”) announced that Norma Beauchamp has resigned as a member of the Company's Board of Directors. The Acerus team and the Company’s Board of Directors thank Ms. Beauchamp for her contribution and commitment to the Company since joining the Board of Directors in 2015 and wish her well in all her future endeavors.

About Acerus

Acerus Pharmaceuticals Corporation is a Canadian-based specialty pharmaceutical company focused on the commercialization and development of innovative prescription products that improve patient experience, with a primary focus in the field of men’s health. The Company commercializes its products via its own salesforce in the United States and Canada, and through a global network of licensed distributors in other territories.

Acerus’ shares trade on TSX under the symbol ASP and on OTCQB under the symbol ASPCF. For more information, visit www.aceruspharma.com and follow us on Twitter and LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200506005276/en/

Edward Gudaitis
President and Chief Executive Officer
[email protected]
(905) 817-8194

Source: Acerus Pharmaceuticals Corporation

You May Also Be Interested In

• Norton Manx R Earns Landmark International Design Excellence Award for Reimagining the Superbike
• How Minecraft's Creator Economy Keeps Growing After 17 Years
• FIA Celebrates Over Ninety Years of Supporting Motor Sport in the United States at the INDYCAR Freedom 250 Grand Prix of Washington D.C.